Discontinuation report ALCON ATROPINE
Report ID | 43530 |
Drug Identification Number | 00035017 |
Brand name | ISOPTO ATROPINE |
Common or Proper name | ISOPTO ATROPINE 1% SOLUTION 5ML |
Company Name | ALCON CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | ATROPINE SULFATE |
Strength(s) | 1% |
Dosage form(s) | SOLUTION |
Route of administration | OPHTHALMIC |
Packaging size | 5ML |
ATC code | S01FA |
ATC description | MYDRIATICSAND CYCLOPLEGICS |
Reason for discontinuation | Other (Please describe in comments) |
Anticipated discontinuation date | |
Actual discontinuation date | 2018-03-13 |
Remaining supply date | 2018-12-31 |
Discontinuation status | Reversed |
Discontinuation decision reversal | Yes |
Information on remaining supply | |
Company comments | WILL NOT BE DISCONTINUED. Product is now available. Novartis Pharmaceuticals has moved to a tight and timely management of inventory for continuity of supply of Isopto Atropine throughout Canada |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2665 MEADOWPINE BLVD MISSISSAUGA, ONTARIO CANADA L5N 8C7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v13 | 2018-08-29 | French | Compare |
v12 | 2018-08-29 | English | Compare |
v11 | 2018-08-14 | French | Compare |
v10 | 2018-08-14 | English | Compare |
v9 | 2018-08-14 | French | Compare |
v8 | 2018-08-14 | French | Compare |
v7 | 2018-08-14 | English | Compare |
v6 | 2018-08-14 | French | Compare |
v5 | 2018-08-14 | English | Compare |
v4 | 2018-08-14 | English | Compare |
v3 | 2018-03-20 | French | Compare |
v2 | 2018-03-20 | English | Compare |
v1 | 2018-03-20 | English | Compare |
Showing 1 to 13 of 13